Bulletins
Browse by topic
- View All
- Agricultural and Vet Science
- Arts, Culture and Performance
- Biology
- Built Environment and Design
- Business and Management
- Chemistry
- COVID-19 Related
- Digital Technology Supercluster
- Earth Sciences
- Economics
- Education
- Engineering
- Environmental Sciences
- History and Archaeology
- Human Society
- Indigenous Studies
- Information and Computing Science
- International Development
- Language, Communications and Culture
- Law and Legal Studies
- Mathematics
- Medical and Health Science
- Philosophy and Religious Studies
- Physics
- Policy and Political Science
- Psychology
- Research Tools
- Technology
Immunodeficiency Canada Research Fellow/Early Investigator Award in Immunodeficiency
The objective of the CAAIF-Immunodeficiency Canada Research Fellow/Early Investigator Award in Immunodeficiency is to support early career investigators doing research into advancement of knowledge into understanding the molecular and genetic basis of primary immunodeficiency as well as breakthroughs in novel treatments for these conditions.
There is one award available for a minimum of $20,000.
Eligibility:
- Applicant must be either:
- postdoctoral fellow, in a research-based fellowship,
- early investigator within the first seven years (with adjustment made for career interruptions*) of completing their degree (PhD or equivalent), OR
- currently in the Clinical Immunology and Allergy Training Program
Application deadline: January 24, 2023 at 11:59 pm in the time zone of the applicant
Click here for more information, eligibility and to apply online
Additional information can be found on the CAAIF Website.
Upcoming Deadlines
External
Internal
January 24, 2024January 24, 2024
*
January 19, 2024
Jan. 19, 2024
January 19, 2024 16:00:00
January 19, 2024 16:00:00
America/Vancouver
Application Deadline: Immunodeficiency Canada Research Fellow/Early Investigator Award in Immunodeficiency
The objective of the award is to support early career investigators doing research into advancement of knowledge into understanding the molecular and genetic basis of primary immunodeficiency as well as breakthroughs in novel treatments for these conditions. There is one award available with a value of $20,000.
.
* NOTE: This deadline is an estimate based on previous years, but a confirmed deadline has not yet been published. We will update the deadline when it has been confirmed.